Loading the company…
Loading the company…
Families: Breast biopsy & localization.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Devicor Medical Products (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2026-01-23.
| Family | Decisions on record |
|---|---|
| Breast biopsy & localization | 9 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-01-23 | 510(k) | K253761 | HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK Plus Breast Biopsy Site Marker (Hummingbird Shape) |
| 2024-07-10 | 510(k) | K240527 | HydroMARK Plus Breast Biopsy Site Marker (Hummingbird Shape) (4010-02-15-T6) |
| 2024-01-12 | 510(k) | K232615 | LumiMARK Biopsy Site Marker (LM0215T (Tulip Shape)); LumiMARK Biopsy Site Marker (LM0215L (Lotus Shape)); LumiMARK Biopsy Site Marker (LM0215R (Rose shape)) |
| 2023-07-13 | 510(k) | K221961 |
| HydroMARK Plus Breast Biopsy Site Marker |
| 2022-04-21 | 510(k) | K212158 | HydroMARK Breast Biopsy Site Marker |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Devicor Medical Products.